Davita - Carmel Health And Living is a medicare approved dialysis facility center in Carmel, Indiana and it has 6 dialysis stations. It is located in Hamilton county at 118 Medical Drive, Suite 114, Carmel, IN, 46032. You can reach out to the office of Davita - Carmel Health And Living at (317) 844-9045. This dialysis clinic is managed and/or owned by Davita. Davita - Carmel Health And Living has the following ownership type - Profit. It was first certified by medicare in December, 2011. The medicare id for this facility is 152650 and it accepts patients under medicare ESRD program.
| Name | Davita - Carmel Health And Living |
|---|---|
| Location | 118 Medical Drive, Suite 114, Carmel, Indiana |
| No. of Dialysis Stations | 6 |
| Medicare ID | 152650 |
| Managed By | Davita |
| Ownership Type | Profit |
| Late Shifts | No |
| 118 Medical Drive, Suite 114, Carmel, Indiana, 46032 | |
| (317) 844-9045 | |
News Archive
Weigh it Up Australia re-launched its FREE online healthy living program last Sunday with more than 6,000 Australians signing up to join the program within the first three days. Weigh it Up's new website offers new and existing members access to more experts and 2 new ways to participate in its healthy living program.
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
Evaluation of PEPFAR, a new report from the Institute of Medicine, presents the results of an assessment of the President's Emergency Plan for AIDS Relief as requested by Congress in its reauthorization of funding for the initiative in 2008.
A new rapid coronavirus test developed by KAUST scientists can deliver highly accurate results in less than 15 minutes.
› Verified 1 days ago
| NPI Number | 1912207150 |
| Organization Name | Carmel Health And Living Dialysis |
| Doing Business As | Total Renal Care Inc |
| Address | 118 Medical Dr Carmel, Indiana, 46032 |
| Phone Number | (317) 844-9045 |
News Archive
Weigh it Up Australia re-launched its FREE online healthy living program last Sunday with more than 6,000 Australians signing up to join the program within the first three days. Weigh it Up's new website offers new and existing members access to more experts and 2 new ways to participate in its healthy living program.
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
Evaluation of PEPFAR, a new report from the Institute of Medicine, presents the results of an assessment of the President's Emergency Plan for AIDS Relief as requested by Congress in its reauthorization of funding for the initiative in 2008.
A new rapid coronavirus test developed by KAUST scientists can deliver highly accurate results in less than 15 minutes.
› Verified 1 days ago
| Dialysis patients with Hemoglobin data | 14 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 21 |
News Archive
Weigh it Up Australia re-launched its FREE online healthy living program last Sunday with more than 6,000 Australians signing up to join the program within the first three days. Weigh it Up's new website offers new and existing members access to more experts and 2 new ways to participate in its healthy living program.
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
Evaluation of PEPFAR, a new report from the Institute of Medicine, presents the results of an assessment of the President's Emergency Plan for AIDS Relief as requested by Congress in its reauthorization of funding for the initiative in 2008.
A new rapid coronavirus test developed by KAUST scientists can deliver highly accurate results in less than 15 minutes.
› Verified 1 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 30 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 172 |
| Percentage of adult patients getting regular hemodialysis at the center | 81 |
News Archive
Weigh it Up Australia re-launched its FREE online healthy living program last Sunday with more than 6,000 Australians signing up to join the program within the first three days. Weigh it Up's new website offers new and existing members access to more experts and 2 new ways to participate in its healthy living program.
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
Evaluation of PEPFAR, a new report from the Institute of Medicine, presents the results of an assessment of the President's Emergency Plan for AIDS Relief as requested by Congress in its reauthorization of funding for the initiative in 2008.
A new rapid coronavirus test developed by KAUST scientists can deliver highly accurate results in less than 15 minutes.
› Verified 1 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita - Carmel Health And Living with elevated calcium levels.
| Patients with hypercalcemia | 31 |
| Hypercalcemia patient months | 181 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | 1 |
| Patients with Serumphosphor | 30 |
| Patients with Serumphosphor less than 3.5 mg/dL | 10 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 27 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 29 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 22 |
| Patients with Serumphosphor greater than 7 mg/dL | 12 |
News Archive
Weigh it Up Australia re-launched its FREE online healthy living program last Sunday with more than 6,000 Australians signing up to join the program within the first three days. Weigh it Up's new website offers new and existing members access to more experts and 2 new ways to participate in its healthy living program.
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
Evaluation of PEPFAR, a new report from the Institute of Medicine, presents the results of an assessment of the President's Emergency Plan for AIDS Relief as requested by Congress in its reauthorization of funding for the initiative in 2008.
A new rapid coronavirus test developed by KAUST scientists can deliver highly accurate results in less than 15 minutes.
› Verified 1 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 36 |
| Patient months included in arterial venous fistula and catheter summaries | 167 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 32 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 23 |
News Archive
Weigh it Up Australia re-launched its FREE online healthy living program last Sunday with more than 6,000 Australians signing up to join the program within the first three days. Weigh it Up's new website offers new and existing members access to more experts and 2 new ways to participate in its healthy living program.
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
Evaluation of PEPFAR, a new report from the Institute of Medicine, presents the results of an assessment of the President's Emergency Plan for AIDS Relief as requested by Congress in its reauthorization of funding for the initiative in 2008.
A new rapid coronavirus test developed by KAUST scientists can deliver highly accurate results in less than 15 minutes.
› Verified 1 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 30 |
| Hospitalization Rate in facility | 189.1 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 359.5 |
| Hospitalization Rate: Lower Confidence Limit | 104.6 |
News Archive
Weigh it Up Australia re-launched its FREE online healthy living program last Sunday with more than 6,000 Australians signing up to join the program within the first three days. Weigh it Up's new website offers new and existing members access to more experts and 2 new ways to participate in its healthy living program.
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
Evaluation of PEPFAR, a new report from the Institute of Medicine, presents the results of an assessment of the President's Emergency Plan for AIDS Relief as requested by Congress in its reauthorization of funding for the initiative in 2008.
A new rapid coronavirus test developed by KAUST scientists can deliver highly accurate results in less than 15 minutes.
› Verified 1 days ago
The rate of readmission show you whether patients who were being treated regularly at Davita - Carmel Health And Living were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 19.3 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 33.7 |
| Readmission Rate: Lower Confidence Limit | 8.9 |
News Archive
Weigh it Up Australia re-launched its FREE online healthy living program last Sunday with more than 6,000 Australians signing up to join the program within the first three days. Weigh it Up's new website offers new and existing members access to more experts and 2 new ways to participate in its healthy living program.
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
Evaluation of PEPFAR, a new report from the Institute of Medicine, presents the results of an assessment of the President's Emergency Plan for AIDS Relief as requested by Congress in its reauthorization of funding for the initiative in 2008.
A new rapid coronavirus test developed by KAUST scientists can deliver highly accurate results in less than 15 minutes.
› Verified 1 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at Davita - Carmel Health And Living get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | 1.53 (As Expected) |
| SIR: Upper Confidence Limit | 4.17 |
| SIR: Lower Confidence Limit | .39 |
News Archive
Weigh it Up Australia re-launched its FREE online healthy living program last Sunday with more than 6,000 Australians signing up to join the program within the first three days. Weigh it Up's new website offers new and existing members access to more experts and 2 new ways to participate in its healthy living program.
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
Evaluation of PEPFAR, a new report from the Institute of Medicine, presents the results of an assessment of the President's Emergency Plan for AIDS Relief as requested by Congress in its reauthorization of funding for the initiative in 2008.
A new rapid coronavirus test developed by KAUST scientists can deliver highly accurate results in less than 15 minutes.
› Verified 1 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether Davita - Carmel Health And Living's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 24 |
| Transfusion Rate in facility | 34 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 129.2 |
| Transfusion Rate: Lower Confidence Limit | 10.5 |
News Archive
Weigh it Up Australia re-launched its FREE online healthy living program last Sunday with more than 6,000 Australians signing up to join the program within the first three days. Weigh it Up's new website offers new and existing members access to more experts and 2 new ways to participate in its healthy living program.
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
Evaluation of PEPFAR, a new report from the Institute of Medicine, presents the results of an assessment of the President's Emergency Plan for AIDS Relief as requested by Congress in its reauthorization of funding for the initiative in 2008.
A new rapid coronavirus test developed by KAUST scientists can deliver highly accurate results in less than 15 minutes.
› Verified 1 days ago
The rate of mortality show you whether patients who were being treated regularly at Davita - Carmel Health And Living lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 145 |
| Mortality Rate in facility | 22.7 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 31.3 |
| Mortality Rate: Lower Confidence Limit | 16 |
News Archive
Weigh it Up Australia re-launched its FREE online healthy living program last Sunday with more than 6,000 Australians signing up to join the program within the first three days. Weigh it Up's new website offers new and existing members access to more experts and 2 new ways to participate in its healthy living program.
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
Evaluation of PEPFAR, a new report from the Institute of Medicine, presents the results of an assessment of the President's Emergency Plan for AIDS Relief as requested by Congress in its reauthorization of funding for the initiative in 2008.
A new rapid coronavirus test developed by KAUST scientists can deliver highly accurate results in less than 15 minutes.
› Verified 1 days ago
FMC - Carmel Location: 12400 North Meridian St., Ste 200, Carmel, Indiana, 46032 Phone: (317) 575-8312 |
Davita - Carmel Dialysis Location: 180 East Carmel Drive, Carmel, Indiana, 46032 Phone: (317) 575-8916 |
Davita - Carmel Health And Living Location: 118 Medical Drive, Suite 114, Carmel, Indiana, 46032 Phone: (317) 844-9045 |
News Archive
Weigh it Up Australia re-launched its FREE online healthy living program last Sunday with more than 6,000 Australians signing up to join the program within the first three days. Weigh it Up's new website offers new and existing members access to more experts and 2 new ways to participate in its healthy living program.
Professor Akiyoshi Fukamizu's research group of Life Science Center for Survival Dynamics, University of Tsukuba, Eisai Co., Ltd. and its gastrointestinal business subsidiary EA Pharma Co., Ltd. have revealed a mechanism in which an analogue (ER-464195-01) of Eisai's in-house discovered E6007 inhibits integrin activation by dissociating interaction between calreticulin (CRT) and integrin α 4 (ITGA4), suppressing adhesion and infiltration of leukocytes overall.
Evaluation of PEPFAR, a new report from the Institute of Medicine, presents the results of an assessment of the President's Emergency Plan for AIDS Relief as requested by Congress in its reauthorization of funding for the initiative in 2008.
A new rapid coronavirus test developed by KAUST scientists can deliver highly accurate results in less than 15 minutes.
› Verified 1 days ago